Indoco Remedies quarterly results and financials

Indoco Remedies (INDOCO)₹219.34+0.22%(9 Nov 2026 close)Pharmaceuticals

Key facts

In the Sep 2026 quarter (consolidated), Indoco Remedies reported sales of ₹521 Cr, up 7.2% from Sep 2025, and net profit of ₹19.04 Cr. For the year to Mar 2026, sales were ₹1,848 Cr and net profit −₹99.21 Cr.

Sales (Sep 2026): ₹521 Cr
Net profit (Sep 2026): ₹19.04 Cr
Sales (FY Mar 2026): ₹1,848 Cr
Net profit (FY Mar 2026): −₹99.21 Cr
EPS (Sep 2026): ₹2.00
Borrowings (Mar 2026): ₹1,088 Cr

Company filings, consolidated accounts; latest reported quarter Sep 2026

Indoco Remedies quarterly results

₹ crore unless stated; each column is a quarter.

Indoco Remedies Quarterly results
	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Sales	460	451	432	434	412	391	441	486	446	477	469	521
Expenses	397	401	384	392	399	391	422	442	414	426	426	474
Operating Profit	62.80	48.77	47.83	39.85	11.95	−0.99	17.93	42.84	31.86	49.82	40.85	45.85
OPM %	13.9%	10.9%	10.9%	8.9%	2.9%	−0.2%	4.0%	8.9%	7.0%	9.9%	8.9%	9.0%
Other Income	−6.02	22.06	1.01	2.01	2.01	2.01	2.01	0.00	−5.01	4.01	100	39.08
Interest	10.04	12.05	14.05	18.08	16.07	18.08	26.11	25.10	26.08	46.22	28.11	27.10
Depreciation	23.97	25.97	27.97	28.95	28.97	28.97	29.99	31.97	31.98	31.97	34.96	33.98
Profit before tax	23.01	33.01	7.01	−4.99	−30.99	−45.97	−37.01	−14.01	−31.01	−25.01	78.02	23.98
Tax %	31.0%	33.0%	74.1%	107.0%	−8.0%	−9.0%	−1.0%	−32.0%	−6.0%	−5.0%	16.0%	20.0%
Exceptional items	−5.65	13.19	0.00	0.00	0.92	0.00	0.00	−0.54	−6.16	3.31	85.18	28.58
Net Profit	16.03	22.05	2.01	−10.03	−28.06	−41.11	−36.08	−9.03	−29.07	−24.05	65.13	19.04
EPS (Rs)	1.78	2.47	0.29	−1.05	−2.87	−4.39	−3.89	−0.87	−3.24	−2.35	7.05	2.00

Indoco Remedies profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Indoco Remedies Profit and loss
	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	1,006	1,073	1,042	970	1,108	1,245	1,545	1,671	1,819	1,669	1,848	1,912
Expenses	834	914	905	891	982	1,017	1,213	1,381	1,572	1,565	1,703	1,740
Operating Profit	170	156	134	76.67	123	224	327	287	244	99.57	141	168
OPM %	17.0%	14.9%	12.9%	7.9%	10.9%	17.9%	20.9%	16.9%	12.9%	6.0%	7.9%	8.8%
Other Income	1.01	4.01	5.01	6.01	2.01	3.01	2.01	1.01	20.05	6.01	0.00	138
Interest	12.04	6.02	24.11	21.08	26.09	22.08	14.06	25.08	38.16	66.31	123	128
Depreciation	60.98	62.94	67.90	71.87	70.87	72.94	78.90	70.93	91.90	114	126	133
Profit before tax	98.97	90.92	47.97	−8.99	29.01	132	237	193	136	−73.95	−106	45.98
Tax %	17.0%	15.0%	15.0%	−69.0%	16.0%	30.0%	35.0%	26.0%	29.0%	5.0%	−7.0%	—
Exceptional items	0.00	1.01	1.01	0.00	0.00	0.00	0.00	−1.01	8.01	1.01	−3.01	111
Net Profit	82.19	77.23	41.12	−3.01	24.07	93.17	155	142	97.24	−78.21	−99.21	31.05
EPS (Rs)	8.90	8.37	4.48	−0.30	2.63	10.11	16.81	15.45	10.69	−8.00	−10.32	3.46
Dividend payout %	18.0%	18.9%	22.0%	−95.0%	11.0%	15.0%	13.0%	15.0%	14.0%	−2.0%	−2.0%	—

Indoco Remedies balance sheet

₹ crore, at each year end.

Indoco Remedies Balance sheet
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	17.92	17.96	17.94	17.95	17.94	17.93	17.97	17.95	17.96	17.94	17.95	17.97
Reserves	499	558	632	656	641	660	750	886	1,010	1,090	1,003	921
Borrowings	96.73	140	279	281	295	261	267	257	332	670	992	1,088
Other Liabilities	231	225	267	282	302	332	280	327	298	365	416	567
Total Liabilities	846	941	1,197	1,238	1,258	1,272	1,315	1,487	1,658	2,144	2,429	2,594
Fixed Assets	340	374	440	489	468	590	570	555	678	953	996	1,193
CWIP	63.04	55.04	90.96	136	185	50.99	67.99	122	114	125	321	89.99
Investments	0.00	16.02	0.00	0.00	0.00	0.00	0.00	0.00	2.01	9.01	1.01	1.01
Other Assets	443	496	666	613	605	631	677	810	865	1,057	1,111	1,310
Inventories	149	167	187	193	183	208	238	311	325	353	419	404
Trade receivables	155	189	216	210	196	210	234	297	351	406	352	490
Cash & equivalents	14.98	12.96	62.90	11.98	35.90	37.89	13.96	19.95	12.97	23.95	16.96	32.90
Total Assets	846	941	1,197	1,238	1,258	1,272	1,315	1,487	1,658	2,144	2,429	2,594

Indoco Remedies cash flow

₹ crore, for each year.

Indoco Remedies Cash flow
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	109	112	89.02	123	132	123	81.99	174	179	157	94.90	192
Cash from investing activity	−88.27	−111	−171	−135	−104	−56.15	−67.22	−121	−209	−434	−340	−102
Cash from financing activity	−19.92	−1.99	132	−38.88	−15.95	−63.76	−29.88	−43.83	22.92	279	240	−76.70
Net cash flow	0.99	0.00	49.96	−50.93	11.98	2.99	−13.98	7.99	−6.98	3.99	−2.99	13.98
Capex	88.84	97.88	190	139	96.75	57.91	76.89	125	206	426	355	148
Free cash flow	20.05	15.03	−100	−15.02	39.10	64.09	6.01	49.08	−27.04	−270	−258	91.18
CFO / OP %	81.0%	82.0%	72.0%	98.0%	177.0%	103.0%	45.0%	66.0%	84.0%	76.0%	112.0%	139.0%

Indoco Remedies ratios

Working-capital days and returns, by year.

Indoco Remedies Ratios
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	65	68	73	72	73	68	68	69	76	81	76	96
Inventory days	182	175	190	204	210	231	246	249	229	231	308	274
Days payable	147	138	167	158	196	184	118	108	87	101	153	209
Cash conversion cycle	101	104	96	118	87	115	196	211	218	211	231	161
Working capital days	46	48	41	38	21	22	59	78	82	62	39	21
ROCE %	20.9%	17.0%	12.0%	7.0%	1.0%	6.0%	15.9%	22.9%	17.0%	10.0%	0.0%	1.0%

Indoco Remedies: frequently asked questions

What are the latest quarterly results of Indoco Remedies?

For the Sep 2026 quarter, Indoco Remedies reported sales of ₹521 Cr, up 7.2% year on year and net profit of ₹19.04 Cr. The operating margin was 9.0%.

What is the annual revenue of Indoco Remedies?

Indoco Remedies' sales for the year to Mar 2026 were ₹1,848 Cr; over the last twelve months they were ₹1,912 Cr.

What is the net profit of Indoco Remedies?

Net profit for the year to Mar 2026 was −₹99.21 Cr, and ₹31.05 Cr over the last twelve months. Earnings per share over the same trailing period were ₹3.46.

How much debt does Indoco Remedies have?

Indoco Remedies reported borrowings of ₹1,088 Cr at Mar 2026, against cash and equivalents of ₹32.90 Cr.

What is the free cash flow of Indoco Remedies?

Cash from operations was ₹192 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹91.18 Cr.

Loading…